Resilia Pharmaceuticals, Inc. Appoints Excitant Healthcare Advertising As Agency of Record for Dermatology Product Line

Mark Perlotto, President, Excitant Healthcare Advertising

February 17, 2021

Atlanta, GA; February 15, 2021>> Excitant Healthcare Advertising announced today that it has been appointed agency of record by Resilia Pharmaceuticals, Inc. Excitant will develop the creative promotion for Resilia Pharmaceuticals’ newly announced Dermatology product line.

Excitant has been the recipient of over 100 healthcare creative awards across a wide range of marketing and advertising initiatives including over 20 in the last year alone.

“We look forward to the award-winning skill, creativity, and launch expertise that Excitant will bring to our marketing operations”, stated Andrew Shales, Resilia’s Chief Executive Officer. “The Dermatology experience Excitant brings to Resilia makes them the ideal partners for communicating about our patient-friendly formulations and the enhanced value that our products bring to physicians and their patients.”

“We are a perfect match for Resilia”, commented Excitant President, Mark Perlotto. “We have a great deal of dermatology experience and a track record of success communicating the benefits of unique technologies–like Resilia’s foam formulations. Excitant is really looking forward to helping Resilia with their initial commercialization efforts.”

About Excitant Healthcare Advertising Excitant is a highly decorated full-service health care marketing and advertising agency with experience and expertise across the pharmaceuticals (Rx & OTC), medical devices and diagnostics segments in both human and animal health. To learn more about Excitant visit

About Resilia Pharmaceuticals, Inc.

Resilia Pharmaceuticals is a privately-held specialty pharmaceuticals company whose products include Ecoza® (econazole nitrate) topical foam, 1%; Recedo® topical gel; the Neosalus® line including cream, foam, and lotion formulations; and Neocera®, a version of Neosalus formulated with ceramides, all of which are currently marketed in the US. To learn more about Resilia Pharmaceuticals and its products, please go to

Contact: Mark Perlotto, President, Excitant Healthcare Advertising 678-357-1127

Post a Comment

You must be logged in to post a Comment.